Bristol-Myers Squibb (BMY) Earnings Date & Reports
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders... Show more
BMY is expected to report earnings to fall 8.98% to $1.52 per share on April 24
Q1'25
Est.
$1.52
Q4'24
Beat
by $0.20
Q3'24
Beat
by $0.30
Q2'24
Beat
by $0.43
Q1'24
Beat
by $0.07
The last earnings report on February 06 showed earnings per share of $1.67, beating the estimate of $1.47. With 9.62M shares outstanding, the current market capitalization sits at 109.66B.